OKE - ONEOK, Inc.
72.20 0.00 (0.00%)
After hours: 6:55PM EST
| Previous Close | 71.59 |
| Open | 71.02 |
| Bid | 72.18 x 800 |
| Ask | 72.19 x 800 |
| Day's Range | 71.00 - 72.35 |
| 52 Week Range | 50.26 - 77.21 |
| Volume | 1,467,671 |
| Avg. Volume | 1,905,006 |
| Market Cap | 29.825B |
| Beta (3Y Monthly) | 1.12 |
| PE Ratio (TTM) | 23.91 |
| EPS (TTM) | 3.02 |
| Earnings Date | Feb 24, 2020 - Feb 28, 2020 |
| Forward Dividend & Yield | 3.66 (5.11%) |
| Ex-Dividend Date | 2019-11-01 |
| 1y Target Est | 76.14 |
- PR Newswire
ONEOK to Present at Wells Fargo Midstream and Utility Symposium
ONEOK, Inc. (NYSE: OKE) will participate in the Wells Fargo Midstream and Utility Symposium Dec. 11-12, 2019, in New York City.
- Insider Monkey
Is ONEOK, Inc. (OKE) Going to Burn These Hedge Funds?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Hedge funds' top 3 stock picks returned 41.7% this year and beat […]
- Zacks
Oneok (OKE) Up 2.1% Since Last Earnings Report: Can It Continue?
Oneok (OKE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- PR Newswire
ONEOK to Participate in the RBC Capital Markets Midstream Conference
TULSA, Okla. , Nov. 18, 2019 /PRNewswire/ -- ONEOK, Inc. (NYSE: OKE) will participate in the RBC Capital Markets Midstream Conference on Nov. 20, 2019 , in Dallas, Texas . Materials used at the conference ...
- Simply Wall St.
Is ONEOK, Inc.'s (NYSE:OKE) 20% ROE Better Than Average?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
- Zacks
UGI Corp's (UGI) Earnings Miss Estimates in Fiscal 2019
UGI Corp's (UGI) Q4 revenues decline on a year-over-year basis.
- Zacks
ONEOK (OKE) to Benefit From Steady Organic Growth Project
ONEOK (OKE) is poised to gain from long-term fee-based commitments.
- Zacks
Atmos Energy (ATO) Q4 Earnings Beat Estimates by a Penny
Atmos Energy's (ATO) fiscal Q4 earnings are better than expected, which is attributable to positive rate outcomes.
- TipRanks
Goldman Sachs Says These 3 Buy-Rated Stocks Are Primed for Growth
With the S&P 500 at record highs, investors are facing an unusual problem: too many places to put their money. A strong jobs report and good news on the US-China trade front have helped to boost the markets; as noted by investment bank Goldman Sachs, in the last week of October over $6.1 billion went back into global stock funds.But where is the smart money going? Goldman economist Silvia Ardagna favors US stocks, but he is careful to hedge his recommendation: “The de-escalation of trade tensions between the U.S. and China has triggered the question whether investors have been too negative and there could be some positive surprises.” He adds that the ongoing US-China trade talks, and the good feelings they have engendered, have his wealthy clients eager to get their money working again. And with that background, we can better understand some of the surprising recommendations that have come from Goldman’s financial research team in recent days. Oneok (OKE)Based in Tulsa, Oklahoma, Oneok is a $12 billion dollar-a-year midstream pipeline company for the natural gas industry in the American West. The company provides midstream services – gathering, processing, storing, transporting, and marketing – for natural gas producers in the Mid-Continent, Permian, and Rocky Mountain production regions. Oneok netted $305.5 million in income in 2018.In its last quarterly report, released on October 30, OKE showed EPS in-line with the estimates, at 74 cents. Revenues, however, missed the forecast by 4.2%, coming in at $2.26 billion against the expected $2.36 billion. The revenue miss was impacted by a combination of expenses due to expanded operations and higher operating costs. While cash flow was down roughly 12% year-over-year, cash on hand was up. Oneok had an impressive $673.3 million in cash and cash equivalents available at the end of September, compared to just $12 million nine months earlier.Goldman analyst Michael Lapides notes the company’s mixed results, but also points out that ‘expanded operations’ specifically means two major pipeline projects expected to come on-line next year. Lapides writes, “OKE is in the late stages of a significant capex cycle, with two large-scale pipeline projects expected to ramp up over the next 6-9 months per management, driving stronger returns, and deleveraging... Given OKE’s asset integration and our wet gas production estimates, we believe there is good visibility to volume growth for these two pipeline projects…”In line with his outlook, Lapides upgrades OKE to a Buy rating, and sets an $81 price target, suggesting an upside of 16% to the stock. (To watch Lapides' track record, click here)OKE is not widely covered by the Street’s analyst corps; among those who do cover the stock, however, the consensus is a Moderate Buy. OKE shows an average price target of $79.33, implying room for about 13% upside from the current trading value of $69.77. (See Oneok's stock analysis on TipRanks)Vir Biotechnology (VIR)This biotech research company, founded in 2016 as a clinical-stage immunology company focusing on the eradication of infectious diseases, had its IPO last month. Since then, it is up 12% in the markets; in its first few weeks of trading, volumes have been modest, and the stock has been volatile.Vir is backed by the Gates Foundation, and has two main projects past the pre-clinical testing phase. A hepatitis B treatment, in collaboration with Alnylam, is in Phase 2 testing, while an Influenza A treatment is in Phase 1 testing. Three more drugs, for TB, HIV, and another for Hep-B, are in the pre-clinical phase. The Gates Foundation is supporting the TB and HIV research. For a small biotech, Vir has a varied pipeline with strong potential.As a new company, Vir hasn’t got a long public record to lean on. That hasn’t stopped Goldman Sachs analyst Paul Choi from initiating coverage of the stock with a Buy rating and an aggressive price target of $37, which implies an impressive upside potential of 133%. (To see Choi's track record, click here)In his initiation report, Choi says, “While we acknowledge that much of the pipeline is early stage, we see significant upside to the stock driven primarily by upcoming Phase 2 HBV and influenza data in 2020, which we think could increase investor confidence in VIR’s platform approach to infectious diseases…” Choi acknowledges that this company is in its early stages, and that the clinical research, while promising, has only just begun. He adds, “…we acknowledge that VIR is several years away from the commercial launch of any of its clinical candidates. We therefore anticipate focus will remain on clinical data over the near-term…”How does Choi's bullish bet weigh in against the Street? It appears the analyst is not the only one enthusiastic on this biotech company's prospects, with TipRanks analytics demonstrating VIR as a Strong Buy. Out of 4 analysts polled by TipRanks in the last 3 months, all 4 are bullish. With a return potential of nearly 100%, the stock’s consensus target price stands at $29. (See Vir's stock analysis on TipRanks)Tal Education Group (TAL)And now we get to a Chinese company. TAL, based in Beijing, describes itself as “a leading education and technology enterprise.” The company’s core focus is on improving science and technology education through integration of internet-based tech in the classroom. TAL has had success in China’s tier-1 cities, and is in process of shifting its priorities to the so-called tier-2 cities.TAL trades on the NYSE, where it has shown a 61% year-to-date gain, nearly triple the S&P gain of 22%. In the company’s most recent quarterly release, for Q2 fiscal 2020, it showed a drop in EPS to 2 cents per share, despite a 33% year-over-year gain in revenues to $936 million. The jump in revenue was attributed to a 54% increase in enrolled students from the year-ago quarter. TAL also boosted Q3 guidance by 41%, to $826 million. Shares spiked after the earnings release, gaining 13%.In a recent report, Goldman’s Christine Cho revisited her firm’s earlier review of TAL and upgraded the rating from Neutral to Buy. Cho wrote, “TAL’s learning center (LC) expansion beyond the top 5 cities has become a key focus in its capacity expansion in recent years. In fact, TAL entered 14/13 new cities in FY19/FY1H20, reaching a footprint of 69 cities as of FY1H20, and learning centers in non-top 5 cities have grown to 52% of the total LC base… We strongly view effective penetration into lower-tier cities as key to long term growth…” Cho’s $50 price target on TAL suggests room for a 15% upside. (To watch Cho's track record, click here)The online education company now looks like a very compelling investing opportunity, as TipRanks analytics showcasing TAL as a Strong Buy. (See Tal Education's stock analysis on TipRanks)
- MoneyShow
3 Midstream Favorites for Rising Quarterly Payouts
Before the energy sector bear market that started in late 2014, most energy midstream companies increased their dividends every single quarter, recalls Tim Plaehn, editor of The Dividend Hunter.
- Market Realist
Top Midstream Energy Stocks: What Analysts Got Wrong
Despite stable earnings and dividend growth, MLP stocks are depressed. We look at the top midstream energy stocks’ performance in the past 12 months.
- Benzinga
Cramer Gives His Opinion On Okta, Oneok And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes Lendingtree Inc (NASDAQ: TREE ) in this environment. The market doesn't like Okta Inc (NASDAQ: OKTA ) right now, said Cramer. He ...
- TheStreet.com
Oneok Shares Could Hit the Gas Soon
What are Jim Cramer's thoughts on Oneok Inc. , the natural gas liquids systems operator? In this daily bar chart of OKE, below, we can see that prices have worked higher from their late December nadir. The daily On-Balance-Volume (OBV) line has maintained an uptrend from the December low and its rise tells us that buyers of OKE have been more aggressive.
- Market Realist
5 Dividend Stocks for an Uncertain Market
The ongoing trade war and geopolitical uncertainties are keeping the stock markets volatile. This may attract investors to dividend stocks.
- Zacks
National Fuel Gas (NFG) Q4 Earnings Beat, Revenues Up Y/Y
National Fuel Gas' (NFG) fourth-quarter fiscal 2019 earnings benefit from overall increase in production across segments.
- Zacks
MDU Resources' (MDU) Earnings and Revenues Rise Y/Y in Q3
Strong operational performance in construction materials and services businesses drives MDU Resources' (MDU) Q3 results.
- Barrons.com
Most Companies Raise Their Dividends Once a Year. Here Are 2 That Raise Them Quarterly.
The boards of publicly traded companies in the U.S. typically declare dividend increases once a year, a longtime practice that many income investors have come to expect. Penske Automotive Group and Oneok have been going quarterly.
- Thomson Reuters StreetEvents
Edited Transcript of OKE earnings conference call or presentation 30-Oct-19 3:00pm GMT
Q3 2019 ONEOK Inc Earnings Call
- Zacks
ONEOK (OKE) Posts In-Line Q3 Earnings, Misses on Revenues
Higher NGL and natural gas volume growth drive ONEOK's (OKE) Q3 earnings.
- Zacks
Oneok Inc. (OKE) Q3 Earnings Match Estimates
Oneok (OKE) delivered earnings and revenue surprises of 0.00% and -4.22%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
- PR Newswire
ONEOK Announces Third Quarter 2019 Earnings; Updates 2019 Financial Guidance and Maintains 2020 Outlook
11% Increase in Net Income Year to Date Announces Completion of Demicks Lake I Natural Gas Processing Plant in the Williston Basin TULSA, Okla. , Oct. 29, 2019 /PRNewswire/ -- ONEOK, Inc. (NYSE: OKE) today ...
- Investing.com
ONEOK Earnings, Revenue Miss in Q3
Investing.com - ONEOK (NYSE:OKE) reported third quarter earnings that missed analysts' expectations on Tuesday and revenue that fell short of forecasts.
- Zacks
ONE Gas (OGS) Q3 Earnings Miss Estimates, Revenues Rise Y/Y
ONE Gas' (OGS) third-quarter 2019 results gain from new rates and customer growth.
- Zacks
Should You Buy ONEOK (OKE) Ahead of Earnings?
ONEOK (OKE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- Simply Wall St.
Should You Like ONEOK, Inc.’s (NYSE:OKE) High Return On Capital Employed?
Today we are going to look at ONEOK, Inc. (NYSE:OKE) to see whether it might be an attractive investment prospect. In...
